Apyx Medical
APYX
31 hedge funds and large institutions have $13.7M invested in Apyx Medical in 2015 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 8 increasing their positions, 8 reducing their positions, and 2 closing their positions.
0% more first-time investments, than exits
New positions opened: 2 | Existing positions closed: 2
0% more repeat investments, than reductions
Existing positions increased: 8 | Existing positions reduced: 8
3% less funds holding
Funds holding: 32 → 31 (-1)
38% less capital invested
Capital invested by funds: $22.1M → $13.7M (-$8.37M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$153K |
| 2 |
WA
Wasatch Advisors
Salt Lake City,
Utah
|
+$91.7K |
| 3 |
Renaissance Technologies
New York
|
+$50.4K |
| 4 |
MLM
Mount Lucas Management
Newtown,
Pennsylvania
|
+$45.8K |
| 5 |
Northern Trust
Chicago,
Illinois
|
+$5.12K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
MAG
Millrace Asset Group
Berwyn,
Pennsylvania
|
-$791K |
| 2 |
KCM
Kennedy Capital Management
St Louis,
Missouri
|
-$289K |
| 3 |
EEG
E.E. Geduld
|
-$70K |
| 4 |
Millennium Management
New York
|
-$48.1K |
| 5 |
ACA
Apis Capital Advisors
New York
|
-$25.2K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
26
Wells Fargo
San Francisco,
California
| $2K | +$2.29K | +1,000 | +100,000% |
|
27
Creative Planning
Overland Park,
Kansas
| $1K | +$1.32K | +575 | New |
|
28
Manulife (Manufacturers Life Insurance)
Canada,
Ontario, Canada
| $4 | – | – | – |
|
|
EEG
29
E.E. Geduld
| – | -$70K | -25,000 | Closed |
|
|
TRCT
30
Tower Research Capital (TRC)
New York
| – | -$21 | -9 | -50% |
|
31
BNP Paribas Financial Markets
Paris,
France
| – | -$6 | -2 | Closed |
|
32
Walleye Trading
New York
| – | +$229 | +100 | New |
|
APYX Hedge Fund Activity: Q3 2015 in Review
31 of the 3,582 institutional investors tracked by Wall St. Rank reported a position in Apyx Medical (APYX) for Q3 2015, worth a combined $13.7M — down 38% from $22.1M a quarter earlier.
Fund positioning in APYX was balanced in Q3 2015: 2 funds opened new positions, 2 closed out, 8 added to existing stakes and 8 trimmed.
The largest buyer was Vanguard Group, adding an estimated $153K. The largest seller was Millrace Asset Group, cutting an estimated $791K.
- 31 institutional investors held Apyx Medical (APYX) as of Q3 2015, down from 32 in Q2 2015.
- Funds reported $13.7M of Apyx Medical stock for Q3 2015, down 38% quarter-over-quarter.
- 2 funds opened new Apyx Medical positions in Q3 2015 and 2 closed out, a net change of 0 holders.
- The largest Apyx Medical buyer in Q3 2015 was Vanguard Group, an estimated $153K added.
- The largest Apyx Medical seller in Q3 2015 was Millrace Asset Group, an estimated $791K sold.
Based on aggregated 13F filings for Q3 2015.